Description
Buy Nutropin AQ (Somatropin) – Product Information, Uses and Pricing
Nutropin AQ is a prescription human growth hormone medication containing somatropin, a recombinant form of naturally occurring human growth hormone. Developed by Genentech, part of the Roche Group, it was used to treat specific growth disorders in children and growth hormone deficiency in adults.
Nutropin AQ works by activating growth hormone receptors and influencing insulin-like growth factor 1 (IGF-1), a hormone involved in skeletal growth, tissue development, and metabolism.
Nutropin AQ Strengths and Formulations
The US product labeling describes several liquid injection presentations, including Nutropin AQ NuSpin 5, NuSpin 10, and NuSpin 20, as well as 10 mg/2 mL and 20 mg/2 mL pen cartridges.
Availability depends on the presentation and market. The US NuSpin presentations were discontinued in December 2024, so current supply must be verified before purchase or dispensing.
Medical Uses
Nutropin AQ was indicated in the United States for growth failure associated with pediatric growth hormone deficiency, idiopathic short stature, Turner syndrome, and chronic kidney disease before renal transplantation. It was also indicated for replacement therapy in adults with confirmed growth hormone deficiency.
Treatment eligibility depends on a medical diagnosis and the applicable prescribing information. Nutropin AQ is not intended for unsupervised height enhancement, bodybuilding, or cosmetic use.
Administration and Storage
Nutropin AQ was formulated as a sterile liquid for subcutaneous injection using its compatible delivery system. Treatment required individualized prescribing, monitoring, and patient education.
The labeled storage requirements included refrigeration at 2–8°C, protection from light, and avoidance of freezing. Specific in-use limits and handling instructions should be checked against the relevant product labeling.
What is Nutropin AQ used for?
Nutropin AQ’s US labeling includes the following indications:
-
Pediatric growth hormone deficiency: Growth failure caused by inadequate secretion of natural growth hormone.
-
Idiopathic short stature: Treatment for certain children who meet the label’s diagnostic and height criteria.
-
Turner syndrome: Treatment of associated short stature.
-
Chronic kidney disease: Treatment of growth failure before kidney transplantation.
-
Adult growth hormone deficiency: Replacement therapy for confirmed deficiency beginning in childhood or adulthood.
Not every child with short stature needs growth hormone treatment. Diagnosis and eligibility require medical assessment, and treatment must be monitored by an appropriately qualified clinician.
4. How Nutropin AQ works
Nutropin AQ supplies somatropin, which binds to growth hormone receptors and influences the production of insulin-like growth factor 1 (IGF-1). These pathways play roles in skeletal growth, protein synthesis, and metabolism.
In eligible children, treatment may improve growth velocity. In adults with confirmed growth hormone deficiency, replacement therapy can help address certain body-composition and metabolic effects of the deficiency. Outcomes vary by patient and clinical circumstances.
5. Administration and storage
Nutropin AQ was designed for subcutaneous injection using the labeled delivery system. The prescribed dose depends on the condition being treated, the patient’s age and weight where applicable, clinical response, and laboratory monitoring.
The US label specifies that the product should be refrigerated at 2–8°C, protected from light, and not frozen. Opened devices have specific in-use storage limits; the label describes a 28-day in-use period under the stated conditions.
Because the product has been discontinued in the US, anyone holding remaining stock should confirm the exact product’s expiry date, storage history, authenticity, and legal eligibility for supply before considering its use or sale.
6. Nutropin AQ price and cost in the USA
The Drugs.com price guide lists the following cash-price references. Because US Nutropin AQ NuSpin presentations were discontinued, treat these as published price-guide figures, not verified current purchase prices.
Published US cash-price references
5 mg / 2 mL
$621.98
Listed supply price
10 mg / 2 mL
$1,231.63
Listed supply price
20 mg / 2 mL
$2,254.85
Listed supply price
Price status
Availability and prices may have changed.




Reviews
There are no reviews yet.